Particular evolutive modalities in SARS-CoV-2 infection

Abstract

The COVID-19 pandemic has challenged the medical world in many ways regarding diagnosis troubles and therapeutic options. In this paper, we will present three cases of patients from different age groups, in which we identified specific ways of evolution, from both clinically and laboratory data point of view. We used a critical evolution risk estimation calculator at admission and compared the results with the subsequent evolution of patients. From the analysis of the presented cases, we found persistent organic damage that will require their long-term follow-up.

Keywords

• sars-cov-2
• covid-19
• admission risk calculator
• tocilizumab
• rt-pcr
• polycythemia